To Be Determined To Be Determined

Alexis Adams serves as the Program Point of Contact for the Centers for Disease Control and Prevention, playing a critical role in aligning acquisition strategies with the agency’s public health mission. Responsible for bridging technical program needs with procurement execution, Adams facilitates the acquisition of advanced computational and data infrastructure to support disease surveillance, outbreak analytics, and laboratory diagnostics. Her work ensures that contracting activities directly enable CDC’s capacity to respond to emerging health threats through real-time data systems, modeling tools, and secure health information platforms. She primarily oversees service-based acquisitions in support of scientific and operational programs, working closely with technical teams to define requirements and evaluate vendor capabilities. Adams maintains strategic relationships with leading pharmaceutical and healthcare distribution firms, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships are centered on the procurement of specialized technical services supporting vaccine logistics, clinical trial data systems, and public health informatics infrastructure. Her engagement with these contractors is characterized by long-term, mission-driven collaboration focused on scalability, regulatory compliance, and interoperability with federal health data networks. Adams’ procurement portfolio reflects a strong preference for full and open competition, with 100% of acquisitions issued without set-aside designations. This indicates a focus on technical capability and mission readiness over socioeconomic categorization, prioritizing vendor expertise and system integration capacity over size-based preferences. Her primary procurement focus is on NAICS 541512 (Computer Systems Design Services), reflecting deep expertise in procuring custom software development, health data analytics platforms, cloud-based surveillance systems, and integrated diagnostic tools. She consistently sources solutions that enhance CDC’s ability to process high-volume public health data, support genomic sequencing initiatives, and deploy secure, interoperable systems across state and local health departments.